ADPT

ADPT R&D Expenses

$88.21MTTM · USD

Period ending:

ADPT FY R&D ExpensesUSD
ADPT FY R&D Expenses2017-12-31: $32.00M2018-12-31: $39.16M2019-12-31: $70.71M2020-12-31: $116.07M2021-12-31: $142.34M2022-12-31: $141.76M2023-12-31: $122.12M2024-12-31: $102.95M2025-12-31: $93.77M$142.34M$0.00
2017-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ADPT r&d expenses history

Research and development spending. The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.

Adaptive Biotechnologies Corp R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
93,769,000
102,953,000
122,117,000
141,756,000
142,343,000
116,072,000
70,705,000
39,157,000
31,995,000

Compare r&d expenses

All ADPT financial metrics · ADPT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.